ACHE and Alzheimer disease: Since AChE is a representative biomarker for Alzheimer’s disease (AD), the TDN-aptamer complex has shown its potential as a sensing platform in real samples, namely, AD patients’ sera, and the detection results were confirmed by ELISA analysis.